Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Chlorotrianisene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | TCF4 | P15884 | 1/20 | 0.58 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 5/20 | 0.56 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorotrianisene SCHEMBL7349593 | 1.00 | HPGD (1.00) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL8613998 | 0.92 | ESR1 (0.85) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL23358693 | 0.92 | ESR1 (0.85) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL23358692 | 0.92 | ESR1 (0.85) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| Chlorotrianisene SCHEMBL4928327 | 0.90 | MAPT (0.81) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL12710298 | 0.87 | SMN1; SMN2 (0.76) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| Chlorotrianisene SCHEMBL28258939 | 0.86 | ALDH1A1 (0.73) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL22773016 | 0.84 | TSHR (0.72) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| Chlorotrianisene SCHEMBL5528225 | 0.83 | MAPT (0.69) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL2957320 | 0.83 | ALDH1A1 (0.70) | HPGDALDH1A1SMN1; SMN2KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 25176 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735116-A2 | ANTI-TRAILR2 ANTIGEN-BINDING PROTEINS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4711364-A1 | FUSED PYRROLE RING OR FUSED PYRIDINE RING COMPOUND | Pharmaengine, Inc. (TW) | 2026-03-18 | — | — | EP | claimed |
| EP-4701737-A2 | MTA-COOPERATIVE PRMT5 INHIBITOR | Pharmaengine, Inc. (TW) | 2026-03-04 | — | — | EP | claimed |
| EP-4695235-A1 | NOVEL GSPT1 DEGRADER AND USE THEREOF | Cyrus Therapeutics Inc. (KR) | 2026-02-18 | — | — | EP | claimed |
| WO-2025227007-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE | OHIO STATE INNOVATION FOUNDATION (US) | 2025-10-30 | — | — | WO | claimed |
| US-12454519-B2 | Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2025-10-28 | — | — | US | claimed |
| US-12454518-B2 | Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2025-10-28 | — | — | US | claimed |
| EP-3710001-B1 | COMPOUNDS AND METHODS FOR REGULATING, LIMITING, OR INHIBITING AVIL EXPRESSION | UNIV VIRGINIA PATENT FOUNDATION (US) | 2025-06-18 | — | — | EP | claimed |
| EP-3324856-B1 | SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025080751-A2 | ANTI-CDH17 ANTIGEN-BINDING PROTEINS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-04-17 | — | — | WO | claimed |
| WO-1991005603-A1 | DEVICE FOR IMPROVING THE EVAPORATION AND/OR THE HOMOGENIZING OF A MIXTURE OF A GASEUS AND/OR LIQUID FLUID | HERAIL RENE (FR) | 1991-05-02 | — | — | WO | claimed |
| US-4729999-A | MENOPAUSE, SIDE EFFECT PREVENTION | BCM TECHNOLOGIES (US) | 1988-03-08 | — | — | US | claimed |
| US-4712765-A | Apparatus for producing coated panels | STELLA WERKE AG (CH) | 1987-12-15 | — | — | US | claimed |
| EP-0247394-A2 | Sealed thrust ball bearing | KOYO SEIKO CO., LTD. (JP) | 1987-12-02 | — | — | EP | claimed |
| EP-0234988-A1 | Propulsion unit combustion chamber and its assembly method | SOCIETE EUROPEENNE DE PROPULSION (FR) | 1987-09-02 | — | — | EP | claimed |
| EP-0178043-A1 | Power supply for electroluminescent panels | LUMINESCENT ELECTRONICS, INC. (US) | 1986-04-16 | — | — | EP | claimed |
| EP-0108584-A1 | Syringes | Dentsply Limited (GB) | 1984-05-16 | — | — | EP | claimed |
| WO-1984001607-A1 | MOTION TRANSMITTING DEVICES | QUADRANT DRIVE (NL) | 1984-04-26 | — | — | WO | claimed |
| US-4310523-A | Combined antiestrogens and antigonadotropically effective antiandrogens for the prophylaxis and therapy of hyperplasia of the prostate | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-01-12 | — | — | US | claimed |
| EP-0010964-A1 | Ravidomycin, process of preparation and pharmaceutical compositions containing same | AYERST, MCKENNA AND HARRISON INC. (CA) | 1980-05-14 | — | — | EP | claimed |